Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Belgium
/
Healthcare
Create a narrative
Ion Beam Applications Community
ENXTBR:IBAB Community
1
Narratives
written by author
0
Comments
on narratives written by author
10
Fair Values set
on narratives written by author
Create a narrative
Ion Beam Applications
Latest
Undervalued
Overvalued
Community Investing Ideas
Ion Beam Applications
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Actinium-225 Production Expansion Will Capitalize On Next-Generation Cancer Treatments
Key Takeaways Proton Therapy installations and clinical evidence driving competitive advantage, with expected growth in service revenues and improved market access, enhancing net and gross margins. Strategic initiatives, including PanTera's actinium-225 venture and division restructuring, support operational efficiency, revenue sustainability, and capital-light growth in nuclear medicine.
View narrative
€17.50
FV
32.1% undervalued
intrinsic discount
9.30%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
1 day ago
author updated this narrative
Your Valuation for
IBAB
IBAB
Ion Beam Applications
Your Fair Value
€
Current Price
€11.88
10.0% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-42m
654m
2015
2018
2021
2024
2025
2027
2030
Revenue €654.5m
Earnings €12.2m
Advanced
Set Fair Value